Research and Markets: Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Pipeline Review 2015
November 27 2015 - 6:14PM
Business Wire
Research and Markets
(http://www.researchandmarkets.com/research/snl5xk/radiation) has
announced the addition of the "Radiation Toxicity (Radiation
Sickness, Acute Radiation Syndrome) - Pipeline Review, H2 2015"
report to their offering.
This report provides comprehensive information on the
therapeutic development for Radiation Toxicity (Radiation Sickness,
Acute Radiation Syndrome), complete with comparative analysis at
various stages, therapeutics assessment by drug target, mechanism
of action (MoA), route of administration (RoA) and molecule type,
along with latest updates, and featured news and press releases. It
also reviews key players involved in the therapeutic development
for Radiation Toxicity (Radiation Sickness, Acute Radiation
Syndrome) and special features on late-stage and discontinued
projects.
The report enhances decision-making capabilities and helps to
create effective counter strategies to gain competitive advantage.
It strengthens R&D pipelines by identifying new targets and
MoAs to produce first-in-class and best-in-class products.
Companies Involved in Therapeutics Development
- Aeolus Pharmaceuticals, Inc.
- Angion Biomedica Corp.
- Atox Bio Inc.
- Avaxia Biologics, Inc.
- Bolder Biotechnology, Inc.
- Caladrius Biosciences, Inc.
- Cantex Pharmaceuticals, Inc.
- Cellerant Therapeutics, Inc.
- Cellphire, Inc.
- Chrysalis BioTherapeutics, Inc.
- Cleveland BioLabs, Inc.
- Cumberland Pharmaceuticals, Inc.
- F. Hoffmann-La Roche Ltd.
- Gamida Cell Ltd.
- GNI Group Ltd.
- Humanetics Corporation
- INSYS Therapeutics, Inc.
- Meabco A/S
- Neumedicines Inc.
- Onconova Therapeutics, Inc.
- PharmaIN Corporation
- Pluristem Therapeutics Inc.
- Priaxon AG
- ProCertus BioPharm Inc.
- RDD Pharma Ltd.
- RedHill Biopharma Ltd.
- RestorGenex Corporation
- RxBio, Inc.
- Soligenix, Inc.
- Stemedica Cell Technologies, Inc.
- Terapio Corporation
- Tonix Pharmaceuticals Holding Corp.
For more information visit
http://www.researchandmarkets.com/research/snl5xk/radiation
View source
version on businesswire.com: http://www.businesswire.com/news/home/20151127005393/en/
Research and MarketsLaura Wood, Senior
Managerpress@researchandmarkets.comFor E.S.T Office Hours Call
1-917-300-0470For U.S./CAN Toll Free Call 1-800-526-8630For GMT
Office Hours Call +353-1-416-8900U.S. Fax: 646-607-1907Fax (outside
U.S.): +353-1-481-1716Sector: Pharmaceuticals